BSE Live
Dec 18, 16:01Prev. Close
1272.00
Open Price
1271.00
Bid Price (Qty.)
1275.00 (2)
Offer Price (Qty.)
1279.60 (27)
NSE Live
Dec 18, 15:58Prev. Close
1272.00
Open Price
1277.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1280.00 (338)
| Key Financial Ratios of Dr Reddys Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 137.18 | 115.45 | 89.93 | 76.76 | 59.06 | |
| Diluted EPS (Rs.) | 136.59 | 114.90 | 89.48 | 76.37 | 58.72 | |
| Cash EPS (Rs.) | 181.71 | 153.39 | 122.32 | 107.25 | 82.57 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 578.23 | 462.12 | 375.09 | 294.16 | 238.29 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 578.23 | 462.12 | 375.09 | 294.16 | 238.29 | |
| Revenue from Operations/Share (Rs.) | 881.65 | 784.91 | 700.57 | 578.69 | 443.08 | |
| PBDIT/Share (Rs.) | 221.11 | 200.97 | 168.99 | 151.14 | 94.89 | |
| PBIT/Share (Rs.) | 176.51 | 162.93 | 136.58 | 120.60 | 71.36 | |
| PBT/Share (Rs.) | 170.16 | 155.48 | 127.49 | 106.39 | 69.91 | |
| Net Profit/Share (Rs.) | 137.11 | 115.35 | 89.92 | 76.70 | 59.04 | |
| NP After MI And SOA / Share (Rs.) | 137.11 | 115.35 | 89.92 | 76.70 | 59.04 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 25.07 | 25.60 | 24.12 | 26.11 | 21.41 | |
| PBIT Margin (%) | 20.02 | 20.75 | 19.49 | 20.83 | 16.10 | |
| PBT Margin (%) | 19.30 | 19.80 | 18.19 | 18.38 | 15.77 | |
| Net Profit Margin (%) | 15.55 | 14.69 | 12.83 | 13.25 | 13.32 | |
| NP After MI And SOA Margin (%) | 15.55 | 14.69 | 12.83 | 13.25 | 13.32 | |
| Return on Networth/Equity (%) | 23.71 | 24.96 | 23.97 | 26.07 | 24.77 | |
| Return on Capital Employed (%) | 19.83 | 19.17 | 19.50 | 19.32 | 21.00 | |
| Return on Assets (%) | 12.56 | 12.24 | 11.32 | 11.48 | 11.14 | |
| Total Debt/Equity (X) | 0.37 | 0.53 | 0.50 | 0.65 | 0.59 | |
| Asset Turnover Ratio (%) | 80.77 | 83.34 | 88.19 | 86.66 | 83.64 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.74 | 1.78 | 1.52 | 1.52 | 1.14 | |
| Quick Ratio (X) | 1.36 | 1.37 | 1.13 | 1.10 | 0.76 | |
| Inventory Turnover Ratio (X) | 5.85 | 5.52 | 5.48 | 5.05 | 4.69 | |
| Dividend Payout Ratio (NP) (%) | 14.58 | 15.59 | 16.68 | 17.91 | 19.06 | |
| Dividend Payout Ratio (CP) (%) | 11.00 | 11.72 | 12.26 | 12.81 | 13.62 | |
| Earnings Retention Ratio (%) | 85.42 | 84.41 | 83.32 | 82.09 | 80.94 | |
| Cash Earnings Retention Ratio (%) | 89.00 | 88.28 | 87.74 | 87.19 | 86.38 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 27.80 | 21.89 | 23.12 | 19.37 | 49.08 | |
| Interest Coverage Ratios (Post Tax) (%) | 27.80 | 21.89 | 23.12 | 19.37 | 49.08 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 61,170.95 | 45,420.42 | 31,139.17 | 31,451.30 | 29,518.27 | |
| EV/Net Operating Revenue (X) | 4.07 | 3.40 | 2.62 | 3.20 | 3.94 | |
| EV/EBITDA (X) | 16.24 | 13.28 | 10.85 | 12.27 | 18.39 | |
| MarketCap/Net Operating Revenue (X) | 3.96 | 3.26 | 2.52 | 3.04 | 3.70 | |
| Retention Ratios (%) | 85.41 | 84.40 | 83.31 | 82.08 | 80.93 | |
| Price/BV (X) | 6.03 | 5.54 | 4.71 | 5.98 | 6.88 | |
| Price/Net Operating Revenue | 3.96 | 3.26 | 2.52 | 3.04 | 3.70 | |
| Earnings Yield | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 |
15.12.2025
12.12.2025
25.11.2025
11.11.2025
28.10.2025
Dr Reddys Labs Consolidated September 2025 Net Sales at Rs 8,828.30 crore, up 9.83% Y-o-Y
28.10.2025
Dr Reddys Labs Standalone September 2025 Net Sales at Rs 4,618.60 crore, down 31.03% Y-o-Y
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
24.07.2025
Dr Reddys Labs Standalone June 2025 Net Sales at Rs 7,809.50 crore, up 33.7% Y-o-Y
22.01.2025
Dr Reddy's Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth
12.07.2023
Dr Reddys Laboratories Q1 PAT seen up 73.7% YoY to Rs 912.4 cr: Nirmal Bang
24.01.2023
Dr Reddy’s Q3 Preview | Sharp drop in net profit likely on slump in US revenues
27.10.2022
Dr Reddy’s Q2 preview: Pharma major likely to report sharp drop in net profit on weak US biz